Howard T. Slayen, a member of the Board of Directors at Aehr Test Systems, Inc. (AEHR -4.71%), sold 20,000 shares of common stock on August 4, 2026, according to an SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Transaction value | $2.2 million |
| Shares sold | 20,000 |
| Post-transaction shares (directly held) | 146,367 |
| Post-transaction value | $16.08 million |
Transaction value based on SEC Form 4 weighted average sale price ($108.30); post-transaction value based on August 4, 2026 market close ($109.89).
Key questions
- How did this transaction affect the director's total equity exposure?
The sale of 20,000 shares reduced Howard Slayen's direct equity interest by 12%, leaving a remaining direct position of ~146,000 shares. - At what valuation was the equity disposed of relative to the trade-date close?
The shares were sold at a weighted average price of $108.30 per share, while the stock was priced at $109.89 at the August 4, 2026 market close. - Are there specific conditions attached to the remaining shares?
The director's remaining direct holdings include shares subject to unvested restricted stock units (RSUs), which ensures a portion of his equity compensation remains subject to future vesting requirements.
Company Overview
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-08-04) | $109.89 |
| Market Capitalization | $3.6 billion |
| Revenue (TTM) | $50.9 million |
| Net Income (TTM) | ($7.1 million) |
Company Snapshot
- Aehr Test Systems designs and manufactures advanced burn-in and test systems for integrated circuits, including logic, optical, and memory devices, with a comprehensive product portfolio featuring the ABTS and FOX-P families of solutions.
- The company generates revenue through the sale of specialized semiconductor test and burn-in equipment, along with complementary components such as WaferPak aligners, contactors, and carriers that support its core testing platforms.
- Aehr serves semiconductor manufacturers and integrated device manufacturers globally who require advanced testing and burn-in capabilities to validate the reliability and performance of their integrated circuit products.
Aehr Test Systems, founded in 1977 and headquartered in Fremont, California, is a specialized provider of advanced burn-in and test solutions for the semiconductor industry. With a market cap of $3.6 billion, the company has demonstrated significant market momentum, with a one-year share price appreciation of 477.46%.
The company's focused product portfolio and specialized expertise in semiconductor testing position it as a critical supplier to manufacturers requiring advanced validation and reliability assessment capabilities for integrated circuits.
What this transaction means for investors
Director Howard Slayen is yet another Aehr Test Systems insider selling after the stock ran up nearly 500% in the past 12 months. His August 4 disposition was a discretionary transaction, which makes sense given the significant share price increase.
The sale reduced holdings by a substantial 12%. That said, Slayen retained over 146,000 shares post-transaction, some of which are unvested RSUs, limiting his ability to dispose of more stock until they vest. This helps to ensure his continued alignment with shareholder interests.
Aehr Test Systems stock rose thanks to a strong earnings report for its fiscal fourth quarter ended May 29. Revenue reached $18.8 million, up from $14.1 million in the prior year.
In addition, the company announced record fiscal Q4 bookings of $60.7 million, and forecasted sales between $130 million and $150 million in its 2027 fiscal year. That’s a massive increase from the $50 million made in fiscal 2026, and sign customer demand is accelerating amid growth in the artificial intelligence sector.
Slayen is a long-time Board member, having served with Aehr Test Systems since 2008.
